Drug Profile
PEG catalase
Latest Information Update: 29 Apr 2011
Price :
$50
*
At a glance
- Originator Enzon Pharmaceuticals
- Developer Enzon Pharmaceuticals; Nonindustrial source
- Class Polyethylene glycols
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Inflammation; Respiratory tract disorders